Loading...
Market
How many countries will approve 'smart' insulin for weekly injections by December 31, 2025?
2
Resolution / Starting Odds
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
Health regulatory bodies' announcements and approvals
Story
'Smart' Insulin Allows Weekly Injections, Mount Sinai Research Offers New Diabetes Treatment
Aug 12, 2024, 01:01 PM
Scientists have developed a new form of 'smart' insulin that responds to changing blood sugar levels in real time, potentially revolutionizing diabetes treatment. This innovative insulin could allow individuals with diabetes to reduce their injections to just once a week, a significant improvement over current treatment regimens. The development is seen as a major breakthrough, with some experts describing it as the 'holy grail' of diabetes management.
View original story
Similar markets
0-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
31 or more countries • 25%
United States • 25%
China • 25%
European Union • 25%
Other • 25%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Yes • 50%
No • 50%
Approved in UK only • 25%
Approved in UK and EU • 25%
Approved in UK, EU, and USA • 25%
Not approved in any major market • 25%
0 countries • 25%
1-5 countries • 25%
6-10 countries • 25%
More than 10 countries • 25%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Novo Nordisk • 25%
Sanofi • 25%
Merck • 25%
Other • 25%
None • 25%
One • 25%
Two • 25%
Three or more • 25%
Less than 10 • 25%
10 to 20 • 25%
20 to 30 • 25%
More than 30 • 25%
<10 countries • 25%
10-20 countries • 25%
20-30 countries • 25%
>30 countries • 25%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%